167 related articles for article (PubMed ID: 19178874)
1. Comparison of pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after single oral administration of L-carnitine in healthy volunteers.
Cao Y; Wang YX; Liu CJ; Wang LX; Han ZW; Wang CB
Clin Invest Med; 2009 Feb; 32(1):E13-9. PubMed ID: 19178874
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
Pace S; Longo A; Toon S; Rolan P; Evans AM
Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
[TBL] [Abstract][Full Text] [Related]
3. HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC.
Kwon OS; Chung YB
Arch Pharm Res; 2004 Jun; 27(6):676-81. PubMed ID: 15283472
[TBL] [Abstract][Full Text] [Related]
4. Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene.
Longo A; Bruno G; Curti S; Mancinelli A; Miotto G
J Chromatogr B Biomed Appl; 1996 Nov; 686(2):129-39. PubMed ID: 8971593
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of L-carnitine and its short-chain acetyl-L-carnitine in patients undergoing carboplatin treatment.
Mancinelli A; D'Iddio S; Bisonni R; Graziano F; Lippe P; Calvani M
Cancer Chemother Pharmacol; 2007 Jun; 60(1):19-26. PubMed ID: 16988826
[TBL] [Abstract][Full Text] [Related]
8. Single dose administration of L-carnitine improves antioxidant activities in healthy subjects.
Cao Y; Qu HJ; Li P; Wang CB; Wang LX; Han ZW
Tohoku J Exp Med; 2011 Jul; 224(3):209-13. PubMed ID: 21701126
[TBL] [Abstract][Full Text] [Related]
9. Excretion and metabolism of propionyl-L-carnitine in the isolated perfused rat kidney.
Evans AM; Mancinelli A; Longo A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1071-6. PubMed ID: 9190838
[TBL] [Abstract][Full Text] [Related]
10. Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver.
Mancinelli A; Longo A; Nation RL; Evans AM
Drug Metab Dispos; 2000 Dec; 28(12):1401-4. PubMed ID: 11095575
[No Abstract] [Full Text] [Related]
11. Disposition of L-carnitine and acetyl-L-carnitine in the isolated perfused rat kidney.
Mancinelli A; Longo A; Shanahan K; Evans AM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1122-8. PubMed ID: 7562478
[TBL] [Abstract][Full Text] [Related]
12. Plasma pharmacokinetics and gastrointestinal transit of a new propionyl-L-carnitine controlled release formulation.
Wagner CC; Rusca A; Kletter K; Tschurlovits M; Pace S; Longo A; Pedrani M; Villa R; Frimonti E; Müller M; Brunner M
Xenobiotica; 2011 Nov; 41(11):988-95. PubMed ID: 21810044
[TBL] [Abstract][Full Text] [Related]
13. Changes in the levels of l-carnitine, acetyl-l-carnitine and propionyl-l-carnitine are involved in perfluorooctanoic acid induced developmental cardiotoxicity in chicken embryo.
Jiang Q; Wang C; Xue C; Xue L; Wang M; Li C; Deng Z; Wang Q
Environ Toxicol Pharmacol; 2016 Dec; 48():116-124. PubMed ID: 27771504
[TBL] [Abstract][Full Text] [Related]
14. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats.
Marzo A; Cardace G; Corbelleta C; Bassani E; Morabito E; Arrigoni Martelli E
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():357-63. PubMed ID: 1820908
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
[TBL] [Abstract][Full Text] [Related]
16. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.
Mingorance C; Rodríguez-Rodríguez R; Justo ML; Alvarez de Sotomayor M; Herrera MD
Vasc Health Risk Manag; 2011; 7():169-76. PubMed ID: 21490942
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
Cavallini G; Modenini F; Vitali G; Koverech A
Urology; 2005 Nov; 66(5):1080-5. PubMed ID: 16286128
[TBL] [Abstract][Full Text] [Related]
18. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
Marzo A; Corsico N; Cardace G; Morabito E
Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
Parnetti L; Gaiti A; Mecocci P; Cadini D; Senin U
Eur J Clin Pharmacol; 1992; 42(1):89-93. PubMed ID: 1541322
[TBL] [Abstract][Full Text] [Related]
20. Effect of carnitine, acetyl-, and propionylcarnitine supplementation on the body carnitine pool, skeletal muscle composition, and physical performance in mice.
Morand R; Bouitbir J; Felser A; Hench J; Handschin C; Frank S; Krähenbühl S
Eur J Nutr; 2014 Sep; 53(6):1313-25. PubMed ID: 24337254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
